Characterization of insulin-like growth factor binding protein-1 kinases from human hepatoma cells

Journal of Cellular Biochemistry

Volumn 60, Issue 3, 1996, Pages 387-399

  Ankrapp, D P ^a   Jones, J I ^a   Clemmons, D R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

casein kinase; growth factor; human hepatoma cells; IGFBP 1; phosphorylation; protein kinase

Indexed keywords

CASEIN KINASE; PROTEIN KINASE; SOMATOMEDIN BINDING PROTEIN 1;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; GROWTH REGULATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASEIN KINASE II; CASEIN KINASES; ENZYME INHIBITORS; GUANOSINE TRIPHOSPHATE; HEPARIN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; ISOQUINOLINES; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE MAPPING; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

EID: 0029873891     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960301)60:3<387::AID-JCB10>3.0.CO;2-I     Document Type: Article

References (31)

1. Baxter RC, Martin JL (1989): Binding proteins for insulin-like growth factors: Structure, regulation and function. Prog Growth Factor Res 1:49-68.
2. Boyle WJ, van der Geer P, Hunter T (1991): Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol 201:110-149.
3. Busby WH, Klapper DG, Clemmons DR (1988a): Purification of a 31000 dalton insulin-like growth factor binding protein from human amniotic fluid. J Biol Chem 263: 14203-14210.
4. Busby WH, Snyder DK, Clemmons DR (1988b): Radioimmunoassay of a 26,000 dalton plasma insulin like growth factor binding protein: Control by nutritional variables. J Clin Endocrinol Metab 67:1225-1230.
5. Chijiwa T, Hagiwara M, Hidaka H (1989): A newly synthesized selective casein kinase I inhibitor, N-(2aminoethyl)-5-chloroisoquinoline-8-sulfonamide, and affinity purification of casein kinase I from bovine testis. J Biol Chem 264:4924-4927.
6. Corvera S, Roach PJ, DePaoli-Roach AA, Czech MP (1988): Insulin action inhibits insulin-like growth factor-II (IGF-II) receptor phosphorylation in H-35 hepatoma cells. J Biol Chem 263:3116-3122.
7. Elgin RG, Busby WH, Clemmons DR (1987): An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84:3254-3258.
8. Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck S, Lee D (1993): Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. J Cell Physiol 157:229-236.
9. Frost EA, Tseng L (1991): Insulin-Like growth factor binding protein 1 (IGFBP-1) is phosphorylated on serine by cultured human endometrial stromal cells and protein kinase A in vitro. J Biol Chem 266:18082-18088.
10. Hathaway GM, Traugh JA (1979): Cyclic nueleotide-independent protein kinases from rabbit reticulocyte. J Biol Chem 254:762-768.
11. Itarte E, Mor MA, Salavert A, Pena JM, Bertomeu JF, Guinovart JJ (1981): Purification and characterization of two cyclic AMP-independent casein/glycogen synthase kinases from rat liver cytosol. Biochim Biophys Acta 658: 334-347.
12. Jones JI, Clemmons DR (1995): Insulin like growth factor and their binding proteins: Biologic actions. Endocrine Rev 16:3-34.
13. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR (1991): Phosphorylation of insulin-like growth factor binding protein 1 in cell culture and in vivo: Effects on affinity for IGF-I. Proc Natl Acad Sci USA 88:7481-7485.
14. Jones JI, Busby WH, Wright G, Smith CE, Kimack NM, Clemmons DR (1993): Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1: Regulation of its affinity by phosphorylation of serine 101. J Biol Chem 268:1125-1131.
15. Jyung RW, Mustoe T, Busby WH, Clemmons DR (1994): Increased wound breaking strength induced by insulin-like growth factor-1 in combination with IGF binding protein-1. Surgery 115:223-239.
16. Kennelly PJ, Krebs EG (1991): Consensus sequences as substrates specificity determinants for protein kinases and protein phosphatases. J Biol Chem 266:15555-15558.
17. Kishimoto A, Brown MS, Slaughter CA, Goldstern JL (1987): Phosphorylation of serine 833 in cytoplasmic domain of low density lipoprotein receptor by a high molecular weight enzyme resembling casein kinase II. J Biol Chem 262: 1344-1351.
18. Koistinen R, Itkinen P, Selenius P, Seppala M (1990): Insulin like growth factor binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. Biochem Biophys Res Commun 173:408-415.
19. Koistinen R, Angervo M, Leinonen P, Hakala T, Seppala M (1993): Phosphorylation of insulin-like growth factor binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. Clin Chim Acta 215: 184-199.
20. Kratz G, Lake M, Ljungstrom K, Forsberg G, Haegerstrand A, Gidlund M (1992): Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: Selective enhancement of IGF-I but not IGF-II induced cell proliferation. Exp Cell Res 202:381-385.
21. Lee YL, Hintz RL, James PM, Lee PDK, Shively JE, Powell DR (1988): Insulin-like growth factor binding protein complementary deoxyribonucleic acid from HepG2 hepatoma cells: Predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol 2: 404-411.
22. Liu L, Brintenman A, Blat C, Harel L (1991): IGFBP-1, an insulin like growth factor binding protein is a cell inhibitor. Biochem Biophys Res Commun 174:673-679.
23. Luo K, Hurley TR, Sefton BM (1990): Transfer of proteins to membranes facilitates both cyanogen bromide cleavage and two-dimensional proteolytic mapping. Oncogene 5:921-923.
24. Meggio F, Boldyrff B, Marin O, Marchiori F, Perich J, Issinger OG, Pinna LA (1992): The effect of polylysine on casein kinase-2 activity is influenced by both the structure of the protein/peptide substrates and the subunit composition of the enzyme Eur J Biochem 205:939-945.
25. Pinna LA (1990): Casein kinase-2: An eminence grise in cellular regulation? Biochim Biophys Acta 1054:267-204.
26. Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voutilainen R, Bohn H, Rutanen EM (1988): Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology 122:2150-2157.
27. Rowles J, Slaughter C, Moomaw C, Hsu J, Cobb MH (1991): Purification of casein kinase I and isolation of cDNAs encoding multiple casein kinase I-like enzymes. Proc Natl Acad Sci USA 88:9548-9552.
28. Singh TJ, Huang KP (1985): Glycogen synthase (casein) kinase-I: Tissue distribution and subcellular localization. FEES Lett 190:34-88.
29. Welsh GI, Price NT, Bladergroen BA, Bloomberg G, Proud CG (1994): Identification of novel phosphorylation sites in the beta-subunit of translation initiation factor eIF-2. Biochem Biophys Res Commun 201:1279-1288.
30. Westwood M, Gibson JM, Davies AJ, Young RJ, White A (1994): The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 79:1735-1741.
31. Zhai L, Graves PR, Longenecker KL, DePaoli-Roach AA, Roach PJ (1992): Recombinant rabbit muscle casein kinase I-alpha is inhibited by heparin and activated by polylysine. Biochem Biophys Res Commun 189:944-949.